Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Research Unit for General Practice, NORCE Norwegian Research Centre, Bergen, Norway.
Fam Pract. 2022 Jan 19;39(1):19-25. doi: 10.1093/fampra/cmab080.
When patients with gastroenteritis (GE) seek health care, they are generally managed in primary care. Little is known about the use of antibiotic treatment in these cases.
The aim of this study was to investigate time trends and patient characteristics associated with antibiotic treatment for GE in Norwegian primary care in a 10-year period.
We linked data from two nationwide registries, reimbursement claims data from Norwegian primary care (the KUHR database) and The Norwegian Prescription Database, for the period 2006-15. GE consultations were extracted, and courses of systemic antibiotics dispensed within 1 day were included for further analyses.
Antibiotic treatment was linked to 1.8% (n = 23 663) of the 1 279 867 consultations for GE in Norwegian primary care in the period 2006-15. The proportion of GE consultations with antibiotic treatment increased from 1.4% in 2006 to 2.2% in 2012 and then decreased to 1.8% in 2015. Fluoroquinolones (28.9%) and metronidazole (26.8%) were most frequently used. Whereas the number of fluoroquinolones courses decreased after 2012, the number of metronidazole courses continued to increase until year 2015. The antibiotic treatment proportion of GE consultations was lowest in young children and increased with increasing age.
Antibiotic treatment is infrequently used in GE consultations in Norwegian primary care. Although there was an overall increase in use during the study period, we observed a reduction in overall use after year 2012. Young children were treated with antibiotics in GE consultations less frequent than older patients.
当患有肠胃炎(GE)的患者寻求医疗保健时,他们通常在初级保健机构接受治疗。对于这些情况下使用抗生素治疗的情况知之甚少。
本研究旨在调查在 10 年期间,挪威初级保健中肠胃炎患者接受抗生素治疗的时间趋势和患者特征。
我们将来自两个全国性登记处的数据进行了关联,即挪威初级保健的报销索赔数据(KUHR 数据库)和挪威处方数据库,研究期间为 2006-15 年。提取了肠胃炎咨询记录,并对在 1 天内开出的全身性抗生素疗程进行了进一步分析。
在 2006-15 年期间,抗生素治疗与挪威初级保健中 1279867 次肠胃炎咨询中的 1.8%(n=23663)相关联。接受抗生素治疗的肠胃炎咨询比例从 2006 年的 1.4%增加到 2012 年的 2.2%,然后在 2015 年降至 1.8%。氟喹诺酮类药物(28.9%)和甲硝唑(26.8%)是最常使用的药物。虽然氟喹诺酮类药物的疗程数量在 2012 年后减少,但甲硝唑的疗程数量继续增加,直到 2015 年。在年轻儿童中,肠胃炎咨询中抗生素治疗的比例最低,随着年龄的增长而增加。
在挪威初级保健中,肠胃炎咨询中抗生素治疗的使用频率较低。尽管在研究期间总体使用呈上升趋势,但我们观察到 2012 年后总体使用量有所减少。在肠胃炎咨询中,年幼的儿童比年长的患者接受抗生素治疗的频率较低。